We are monitoring the impact of COVID-19 on Europe Narcolepsy Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6662
Share on
Share on

Europe Narcolepsy Drugs Market Research Report – Segmented By Type, Indication and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) – Industry Size, Share, Trends and Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 6662
Pages: 145

Europe Narcolepsy Drugs Market Size (2020 to 2025)

The size of the Narcolepsy Drugs Market in Europe is predicted to showcase a robust CAGR from 2020 to 2025. Narcolepsy is a neurological disorder that decreases the ability to regulate sleep cycles.

It is a long-term neurological disorder that includes periods of excessive daytime sleepiness that last from seconds to minutes and can occur at any time. Sometimes these sessions can cause sudden loss of muscle loss that is termed as cataplexy, and occurs in 70% of the cases. Currently there is no cure but lifestyle changes and medications help in developing tolerance to the disorder.

Factors accountable for the growth of market are increasing number of individuals affected by these conditions and increasing severity of the diseases, favourable reimbursement policies and increasing awareness regarding the medications available to treat the disorder. On the other hand, expensive manufacturing costs and strict regulations are the factors hindering the market.

The Europe market for Narcolepsy Drugs is segmented based on Type and Indication. Based on Type it is divided into Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others. Based on Indications it is divided into Daytime Extreme Sleepiness, Cataplexia and Others. Based on geographical analysis, the market is divided into regions of U.K., Germany, France, Italy and Spain. U.K. holds the major share in the market due to presence of market leaders as well as the presence of a stellar healthcare system. Germany is the fastest growing region due to increasing disposable income, growing awareness and increasing adoption rate.

Top companies dominating the European Narcolepsy Drugs Market profiled in this report are Ligand Pharmaceuticals, Addrenex Pharmaceuticals, Shire Plc, Teva Pharmaceutical Industries Ltd., Arena Pharmaceuticals, Jazz Pharmaceuticals Plc, Bioprojet, and Graymark Healthcare, Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Central Nervous System Stimulants             

                                5.1.3 Tricyclic Antidepressants   

                                5.1.4 Sodium Oxybate   

                                5.1.5 Selective Serotonin Reuptake Inhibitor      

                                5.1.6 Others      

                                5.1.7  Y-o-Y Growth Analysis, By Type    

                                5.1.8  Market Attractiveness Analysis, By Type  

                                5.1.9  Market Share Analysis, By Type    

                5.2 Indication                    

                                5.2.1 Introduction           

                                5.2.2 Daytime Extreme Sleepiness          

                                5.2.3 Cataplexia               

                                5.2.4 Others      

                                5.2.5 Y-o-Y Growth Analysis, By Indication           

                                5.2.6 Market Attractiveness Analysis, By Indication         

                                5.2.7 Market Share Analysis, By Indication           

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Indication

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Indication

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Ligand Pharmaceuticals                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Addrenex Pharmaceuticals                  

                8.3 Shire Plc                       

                8.4 Teva Pharmaceutical Industries Ltd.                

                8.5 Arena Pharmaceuticals                          

                8.6 Jazz Pharmaceuticals Plc                       

                8.7 Bioprojet                     

                8.8 Graymark Healthcare, Inc                     

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by indication along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Narcolepsy Drugs Market, By Type, From 2020 to 2025 (USD Million)
  2. Europe Central Nervous System Stimulants Market, By Region, From 2020 to 2025 (USD Million)
  3. Europe Tricyclic Antidepressants Market, By Region, From 2020 to 2025 (USD Million)
  4. Europe Sodium Oxybate Market, By Region, From 2020 to 2025 (USD Million)
  5. Europe Selective Serotonin Reuptake Inhibitor Market, By Region, From 2020 to 2025 (USD Million)
  6. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  7. Europe Narcolepsy Drugs Market, By Indication, From 2020 to 2025 (USD Million)
  8. Europe Daytime Extreme Sleepiness Market, By Region, From 2020 to 2025 (USD Million)
  9. Europe Cataplexia Market, By Region, From 2020 to 2025 (USD Million)
  10. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  11. U.K. Narcolepsy Drugs Market, By Type, From 2020 to 2025 (USD Million)
  12. U.K. Narcolepsy Drugs Market, By Indication, From 2020 to 2025 (USD Million)
  13. Germany Narcolepsy Drugs Market, By Type, From 2020 to 2025 (USD Million)
  14. Germany Narcolepsy Drugs Market, By Indication, From 2020 to 2025 (USD Million)
  15. France Narcolepsy Drugs Market, By Type, From 2020 to 2025 (USD Million)
  16. France Narcolepsy Drugs Market, By Indication, From 2020 to 2025 (USD Million)
  17. Italy Narcolepsy Drugs Market, By Type, From 2020 to 2025 (USD Million)
  18. Italy Narcolepsy Drugs Market, By Indication, From 2020 to 2025 (USD Million)
  19. Spain Narcolepsy Drugs Market, By Type, From 2020 to 2025 (USD Million)
  20. Spain Narcolepsy Drugs Market, By Indication, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample